We do not predict market levels, what we focus on is valuations which are still above average. Small and mid-cap are expensive while large caps are in the fair value zone. We have an internal model for asset allocation which is used for equity allocation in some of our asset allocation strategies and that model is suggesting around 60-65% asset allocation to equity.
Dr Reddy’s Labs Q4 Results: Cons PAT jumps 22% to Rs 1,594 crore; Rs 8 per share dividend announced
Dr Reddy’s Labs Q4 Results: Dr Reddy’s Laboratories on Friday reported a consolidated net profit growth of 22% to Rs 1,594 crore in Q4FY25 versus